Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study examines the physical capacity of lung cancer patients assessed with the six minute walk test and handgrip strength. Demographic and selfreported exercise behavior is registered to explore correlations to functional and physical capacity.
Assessments are made before first chemotherapy cycle and after fourth chemotherapy cycle, an expected average of 12 weeks between first and second assessment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| lung cancer patients | Non Small Cell Lung Cancer, Small Cell Lung Cancer |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Mortality - Survival time | Prognostic value of the six minute walk and handgrip strength on mortality | time from first chemotherapy treatment to death, assessed after 30 months |
| Measure | Description | Time Frame |
|---|---|---|
| Hand grip strength | before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment. | |
| Self reported exercise behavior | before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment. |
| Measure | Description | Time Frame |
|---|---|---|
| FACT-L | Patient reported outcome | Before first chemotherapy and after fourth cycle of chemotherapy, an expected average of 12 weeks between first and second assessment. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Non Small Cell Lung Cancer Stage Small Cell Lung Cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Seppo Langer, Phd. | University Hospital of Copenhagen, Rigshospitalet | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital of Copenhagen | Copenhagen | 2200 | Denmark |
Not provided
| Label | URL |
|---|---|
| Related Info | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung |
| D055752 | Small Cell Lung Carcinoma |
| ID | Term |
|---|---|
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Six minute walk test | Before first and after fourth chemotheraphy cycle, an expected average of 12 weeks between first and second assessment. |
| D013899 |
| Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |